A groundbreaking study from the University of Sydney has revealed how type 2 diabetes can fundamentally alter the structure and function of the human heart. Published in EMBO Molecular Medicine, the research sheds new light on why individuals with diabetes face a heightened risk of heart failure. The findings not only deepen our understanding of the link between diabetes and heart disease but also open the door to potential new treatment strategies.

Using human heart tissue donated by patients undergoing heart transplants in Sydney, researchers led by Dr. Benjamin Hunter and Associate Professor Sean Lal discovered that diabetes triggers specific molecular and structural changes in the heart. These changes are particularly pronounced in individuals suffering from ischemic cardiomyopathy, a common form of heart failure caused by restricted blood flow to the heart muscle.

“We’ve long seen a correlation between heart disease and type 2 diabetes,” Dr. Hunter explained, “but this is the first research to jointly look at diabetes and ischemic heart disease and uncover a unique molecular profile in people with both conditions.” This insight is especially significant given that heart disease remains the leading cause of death in Australia, where over 1.2 million people live with type 2 diabetes.

The study found that diabetes disrupts how the heart produces energy, maintains its structure under stress, and contracts to pump blood. One of the most striking discoveries was the presence of a fibrous tissue build-up in the heart muscle, a change that compromises the heart’s ability to function efficiently. I found this detail striking because it illustrates how diabetes can have a direct, physical impact on heart tissue, beyond its well-known metabolic effects.

To reach these conclusions, the researchers examined heart tissue from both transplant recipients and healthy donors. Their analysis revealed that diabetes does more than coexist with heart disease—it actively worsens heart failure by interfering with essential biological processes. These disruptions occur at the microscopic level, reshaping the heart muscle and altering its performance.

Dr. Hunter noted that under normal conditions, the heart uses a combination of fats, glucose, and ketones for energy. In heart failure, glucose uptake is known to increase. However, diabetes reduces the insulin sensitivity of glucose transporters—proteins responsible for moving glucose into heart muscle cells. This resistance hampers the heart’s ability to generate energy efficiently, placing added stress on mitochondria, the cell’s energy producers.

Furthermore, the study observed a decline in the production of structural proteins necessary for heart muscle contraction and calcium regulation. These proteins are vital for the rhythmic pumping action of the heart. Their reduction, coupled with the accumulation of fibrous tissue, significantly impairs the heart’s ability to circulate blood effectively.

To validate their findings, the researchers used RNA sequencing to examine gene expression levels. They found that many of the observed protein changes corresponded with alterations at the genetic level, particularly in pathways related to energy metabolism and tissue structure. Confocal microscopy then confirmed these changes within the heart tissue itself, providing a comprehensive view of how diabetes reshapes the heart at both molecular and structural levels.

Associate Professor Lal emphasized the potential implications of these findings. “Now that we’ve linked diabetes and heart disease at the molecular level and observed how it changes energy production in the heart while also changing its structure, we can begin to explore new treatment avenues,” he said. This connection could also inform diagnostic criteria and lead to more effective disease management strategies, improving care for millions of patients worldwide.

The discovery of mitochondrial dysfunction and fibrotic pathways in diabetic heart tissue offers promising targets for future therapies. By understanding the specific ways in which diabetes alters heart function, researchers and clinicians can develop more tailored interventions aimed at preserving heart health in diabetic patients.

While the metabolic effects of diabetes have been studied extensively, this research provides one of the clearest pictures yet of how those effects manifest in the human heart. It moves beyond correlation to demonstrate causation at a molecular level, offering a new framework for understanding and treating diabetic heart disease.

For those living with type 2 diabetes, this study underscores the importance of cardiovascular health management. It also highlights the need for continued research into how systemic conditions like diabetes can influence the function of individual organs. As scientists build on these findings, the hope is that targeted treatments can mitigate the cardiovascular risks associated with diabetes and improve long-term outcomes for patients.

Read more at medicalxpress.com